Literature DB >> 33248227

Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine.

R Casolino1, C Braconi2, G Malleo3, S Paiella3, C Bassi3, M Milella4, S B Dreyer5, F E M Froeling6, D K Chang5, A V Biankin7, T Golan8.   

Abstract

This review summarises the recent evidence on preoperative therapeutic strategies in pancreatic cancer and discusses the rationale for an imminent need for a personalised therapeutic approach in non-metastatic disease. The molecular diversity of pancreatic cancer and its influence on prognosis and treatment response, combined with the failure of 'all-comer' treatments to significantly impact on patient outcomes, requires a paradigm shift towards a genomic-driven approach. This is particularly important in the preoperative, potentially curable setting, where a personalised treatment allocation has the substantial potential to reduce pancreatic cancer mortality.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Pancreatic cancer; neoadjuvant; precision medicine; predictive biomarkers; preoperative; prognostic biomarkers

Mesh：

Substances：

Year:  2020        PMID： 33248227      PMCID： PMC7840891          DOI： 10.1016/j.annonc.2020.11.013

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


  99 in total

Review 1.  The emerging clinical relevance of genomics in cancer medicine.

Authors:  Michael F Berger; Elaine R Mardis
Journal:  Nat Rev Clin Oncol       Date:  2018-06       Impact factor: 66.675

2.  Waiting time to surgery and pancreatic cancer survival: A nationwide population-based cohort study.

Authors:  Jakob Kirkegård; Frank Viborg Mortensen; Carsten Palnæs Hansen; Michael Bau Mortensen; Mogens Sall; Claus Fristrup
Journal:  Eur J Surg Oncol       Date:  2019-05-28       Impact factor: 4.424

3.  First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma.

Authors:  Pat Gulhati; Laura Prakash; Matthew H G Katz; Xuemei Wang; Milind Javle; Rachna Shroff; David Fogelman; Jeffrey E Lee; Ching-Wei D Tzeng; Jeffrey H Lee; Brian Weston; Eric Tamm; Priya Bhosale; Eugene J Koay; Anirban Maitra; Huamin Wang; Robert A Wolff; Gauri R Varadhachary
Journal:  Ann Surg Oncol       Date:  2018-10-15       Impact factor: 5.344

4.  Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis.

Authors:  Quisette P Janssen; Stefan Buettner; Mustafa Suker; Berend R Beumer; Pietro Addeo; Philippe Bachellier; Nathan Bahary; Tanios Bekaii-Saab; Maria A Bali; Marc G Besselink; Brian A Boone; Ian Chau; Stephen Clarke; Mary Dillhoff; Bassel F El-Rayes; Jessica M Frakes; Derek Grose; Peter J Hosein; Nigel B Jamieson; Ammar A Javed; Khurum Khan; Kyu-Pyo Kim; Song Cheol Kim; Sunhee S Kim; Andrew H Ko; Jill Lacy; Georgios A Margonis; Martin D McCarter; Colin J McKay; Eric A Mellon; Sing Yu Moorcraft; Ken-Ichi Okada; Alessandro Paniccia; Parag J Parikh; Niek A Peters; Hans Rabl; Jaswinder Samra; Christoph Tinchon; Geertjan van Tienhoven; Eran van Veldhuisen; Andrea Wang-Gillam; Matthew J Weiss; Johanna W Wilmink; Hiroki Yamaue; Marjolein Y V Homs; Casper H J van Eijck; Matthew H G Katz; Bas Groot Koerkamp
Journal:  J Natl Cancer Inst       Date:  2019-08-01       Impact factor: 13.506

Review 5.  Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy.

Authors:  Gauri R Varadhachary; Eric P Tamm; James L Abbruzzese; Henry Q Xiong; Christopher H Crane; Huamin Wang; Jeffrey E Lee; Peter W T Pisters; Douglas B Evans; Robert A Wolff
Journal:  Ann Surg Oncol       Date:  2006-07-24       Impact factor: 5.344

6.  Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine.

Authors:  Andrew J Aguirre; Jonathan A Nowak; Nicholas D Camarda; Richard A Moffitt; Arezou A Ghazani; Mehlika Hazar-Rethinam; Srivatsan Raghavan; Jaegil Kim; Lauren K Brais; Dorisanne Ragon; Marisa W Welch; Emma Reilly; Devin McCabe; Lori Marini; Kristin Anderka; Karla Helvie; Nelly Oliver; Ana Babic; Annacarolina Da Silva; Brandon Nadres; Emily E Van Seventer; Heather A Shahzade; Joseph P St Pierre; Kelly P Burke; Thomas Clancy; James M Cleary; Leona A Doyle; Kunal Jajoo; Nadine J McCleary; Jeffrey A Meyerhardt; Janet E Murphy; Kimmie Ng; Anuj K Patel; Kimberly Perez; Michael H Rosenthal; Douglas A Rubinson; Marvin Ryou; Geoffrey I Shapiro; Ewa Sicinska; Stuart G Silverman; Rebecca J Nagy; Richard B Lanman; Deborah Knoerzer; Dean J Welsch; Matthew B Yurgelun; Charles S Fuchs; Levi A Garraway; Gad Getz; Jason L Hornick; Bruce E Johnson; Matthew H Kulke; Robert J Mayer; Jeffrey W Miller; Paul B Shyn; David A Tuveson; Nikhil Wagle; Jen Jen Yeh; William C Hahn; Ryan B Corcoran; Scott L Carter; Brian M Wolpin
Journal:  Cancer Discov       Date:  2018-06-14       Impact factor: 39.397

7.  Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.

Authors:  Talia Golan; Pascal Hammel; Michele Reni; Eric Van Cutsem; Teresa Macarulla; Michael J Hall; Joon-Oh Park; Daniel Hochhauser; Dirk Arnold; Do-Youn Oh; Anke Reinacher-Schick; Giampaolo Tortora; Hana Algül; Eileen M O'Reilly; David McGuinness; Karen Y Cui; Katia Schlienger; Gershon Y Locker; Hedy L Kindler
Journal:  N Engl J Med       Date:  2019-06-02       Impact factor: 91.245

8.  Stereotactic body radiation therapy for locally advanced pancreatic cancer.

Authors:  Jinhong Jung; Sang Min Yoon; Jin-Hong Park; Dong-Wan Seo; Sang Soo Lee; Myung-Hwan Kim; Sung Koo Lee; Do Hyun Park; Tae Jun Song; Baek-Yeol Ryoo; Heung-Moon Chang; Kyu-Pyo Kim; Changhoon Yoo; Jae Ho Jeong; Song Cheol Kim; Dae Wook Hwang; Jae Hoon Lee; Ki Byung Song; Yoon Young Jo; Jongmoo Park; Jong Hoon Kim
Journal:  PLoS One       Date:  2019-04-12       Impact factor: 3.240

9.  The 2019 WHO classification of tumours of the digestive system.

Authors:  Iris D Nagtegaal; Robert D Odze; David Klimstra; Valerie Paradis; Massimo Rugge; Peter Schirmacher; Kay M Washington; Fatima Carneiro; Ian A Cree
Journal:  Histopathology       Date:  2019-11-13       Impact factor: 5.087

10.  Do we need sequential local therapy following neoadjuvant chemotherapy for locally advanced pancreatic cancer?

Authors:  Jörg Kleeff; Ulrich Ronellenfitsch; Christoph W Michalski
Journal:  EClinicalMedicine       Date:  2019-12-04
View more
  9 in total

Review 1.  Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care.

Authors:  Raffaella Casolino; Vincenzo Corbo; Philip Beer; Chang-Il Hwang; Salvatore Paiella; Valentina Silvestri; Laura Ottini; Andrew V Biankin
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

Review 2.  Advanced iron oxide nanotheranostics for multimodal and precision treatment of pancreatic ductal adenocarcinoma.

Authors:  Lei Zhu; Hui Mao; Lily Yang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2022-04-09

3.  Inhibition of TRIM32 by ibr-7 treatment sensitizes pancreatic cancer cells to gemcitabine via mTOR/p70S6K pathway.

Authors:  Bo Zhang; You-You Yan; Yang-Qin Gu; Fei Teng; Xu Lin; Xing-Lu Zhou; Jin-Xin Che; Xiao-Wu Dong; Li-Xin Zhou; Neng-Ming Lin
Journal:  J Cell Mol Med       Date:  2021-12-17       Impact factor: 5.310

Review 4.  Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine.

Authors:  Federica Vernuccio; Carlo Messina; Valeria Merz; Roberto Cannella; Massimo Midiri
Journal:  Diagnostics (Basel)       Date:  2021-11-22

5.  Synergistic blocking of RAS downstream signaling and epigenetic pathway in KRAS mutant pancreatic cancer.

Authors:  Xiaofei Zhang; Tiebo Mao; Haiyan Xu; Shumin Li; Ming Yue; Jingyu Ma; Jiayu Yao; Yongchao Wang; Xiao Zhang; Weiyu Ge; Yanling Wang; Daiyuan Shentu; Liwei Wang
Journal:  Aging (Albany NY)       Date:  2022-04-25       Impact factor: 5.682

Review 6.  Does the Microenvironment Hold the Hidden Key for Functional Precision Medicine in Pancreatic Cancer?

Authors:  John Kokkinos; Anya Jensen; George Sharbeen; Joshua A McCarroll; David Goldstein; Koroush S Haghighi; Phoebe A Phillips
Journal:  Cancers (Basel)       Date:  2021-05-17       Impact factor: 6.639

7.  Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis.

Authors:  Raffaella Casolino; Salvatore Paiella; Danila Azzolina; Philip A Beer; Vincenzo Corbo; Giulia Lorenzoni; Dario Gregori; Talia Golan; Chiara Braconi; Fieke E M Froeling; Michele Milella; Aldo Scarpa; Antonio Pea; Giuseppe Malleo; Roberto Salvia; Claudio Bassi; David K Chang; Andrew V Biankin
Journal:  J Clin Oncol       Date:  2021-07-01       Impact factor: 50.717

8.  Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus.

Authors:  A Carrato; L Cerezo; J Feliu; T Macarulla; E Martín-Pérez; R Vera; J Álvarez; J I Botella-Carretero
Journal:  Clin Transl Oncol       Date:  2021-08-07       Impact factor: 3.405

9.  Sensory Ion Channel Candidates Inform on the Clinical Course of Pancreatic Cancer and Present Potential Targets for Repurposing of FDA-Approved Agents.

Authors:  Wenjie Shi; Chen Li; Thomas Wartmann; Christoph Kahlert; Renfei Du; Aristotelis Perrakis; Thomas Brunner; Roland S Croner; Ulf D Kahlert
Journal:  J Pers Med       Date:  2022-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.